Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on May 6, 2025

Galimedix Therapeutics completes single ascending dose part of Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modulator
GAL-101 well tolerated; excellent safety and pharmacokinetic profile strongly supports oral administration Next arms of study, including multiple ascending dose (MAD), underway and expected to complete in late 2025 Planned indications include dry age- …

Lingokids puts Parent Guilt on Trial in First of its Kind Campaign
LOS ANGELES, May 06, 2025 (GLOBE NEWSWIRE) -- Today, Lingokids, the #1 interactive app for kids aged 2-8, puts the parenting screen time debate on trial with the launch of its largest U.S. campaign, The Trial by Lingokids. The campaign film highlights the …

Coralogix Launches Advanced Continuous Profiling to Accelerate Issue Resolution Without Slowing Production
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Coralogix, the first cross-stack observability platform provider, today announced Continuous Profiling, an advanced capability that delivers unparalleled real-time visibility into application performance without any …

Strong Majority of Consumers Express Deep Concern Over Tariff-Driven Price Increases, Optimove Insights Survey Finds
New York, May 06, 2025 (GLOBE NEWSWIRE) -- A strong majority (55%) of U.S. consumers are 'very concerned' about tariffs, stating that price increases are already impacting their budgets, according to new survey results released today by Optimove Insights, …

ParaZero Receives Significant European Order for SafeAir™ M4 Systems from Leading Drone Technology Distributor
Order reflects growing demand for ParaZero’s advanced drone safety solutions across the European commercial and enterprise sectors TEL AVIV, Israel, May 06, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "company” or “ParaZero”), …

VAXIL: SHARE CONSOLIDATION
Not for distribution by US newswire or in United States TORONTO, May 06, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), is pleased to make the following updates regarding the Company’s activities. Vaxil announces …

PeerGame Introduces Seamless Crypto Transactions with WalletConnect Integration
London, UK, May 06, 2025 (GLOBE NEWSWIRE) -- Leading cryptocurrency gaming company PeerGame has announced the launch of its new cashier system - its platform will now be integrated with WalletConnect for seamless, secure, and fast crypto transactions. The …

Stardust Power Announces First Quarter 2025 Earnings Release Date, Conference Call
GREENWICH, Conn., May 06, 2025 (GLOBE NEWSWIRE) -- Stardust Power Inc. (NASDAQ: SDST) (“Stardust Power” or the “Company”), an American developer of battery-grade lithium products, today announced that it will release its first quarter 2025 financial …

Amerigo Announces Results of AGM
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; ARREF:OTC) (“Amerigo” or the “Company”) announces the results of voting at its 2025 Annual General Meeting of Shareholders (the “AGM”) held on May 5, 2025. A …

Altimmune to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025
GAITHERSBURG, Md., May 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2025 financial results on Tuesday, May 13, 2025. Altimmune management …

Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress
- Favorable clinical data in PD-(L)1 resistant patients - - Dose expansion enrollment complete with full data expected by year-end 2025 - - Cash runway into the second quarter of 2026 - BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. …

Kura Oncology to Participate in Bank of America Securities Healthcare Conference
SAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in Bank of …

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
‒ Q1 2025 Net Revenue of $39.1mm; Adjusted EBITDA of $23.6mm ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time BERKELEY HEIGHTS, NJ., May 06, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on …

Genie Energy Announces First Quarter 2025 Results
Newark, NJ, May 06, 2025 (GLOBE NEWSWIRE) -- Genie Energy, Ltd. (NYSE: GNE), a leading retail energy and renewable energy solutions provider, today announced results for the first quarter of 2025. Michael Stein, Chief Executive Officer of Genie Energy, …

Bioventus Reports First Quarter Financial Results
Q1 reported revenue of $123.9 million declined 4.3%; Organic* revenue advanced 5.0% First quarter net loss was $0.04 per share compared to a loss of $0.08 in the prior-year period Non-GAAP earnings* of $0.08 per share increased 33% Company reiterated …

Sono Hits the Road: Confirmed Trade Show Appearances Across Europe in 2025
Munich, Germany, May 06, 2025 (GLOBE NEWSWIRE) -- The solar technology company Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as “Sono Group” or “Sono”, parent company to Sono Motors GmbH or “Sono Motors”) is pleased to announce its confirmed …

Neuronetics Reports First Quarter 2025 Financial and Operating Results
MALVERN, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of …

Kraig Biocraft Laboratories Successfully Completes March/April Production Cycle; May Production Now Underway
ANN ARBOR, Mich., May 06, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it has successfully completed its March/April spider silk …

Y-mAbs to Announce First Quarter 2025 Financial and Operating Results on May 13, 2025
PRINCETON, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody- …

Pasithea Therapeutics Reports Positive Pharmacodynamic Results Demonstrating Robust Target Engagement from its Ongoing Phase 1 Clinical Trial of PAS-004
-- PAS-004 shows up to 91% inhibition of pERK, confirming substantial target engagement -- -- One patient in cohort 4A with stage 4 KRAS G12R mutated pancreatic cancer achieves over 5 months of stable disease with tumor volume reduction of -9.8% -- MIAMI, …